Lantheus Holdings, Inc

Add to watchlist
€20.0
Last updated:06/15/2021
0L8: F
Lantheus Holdings, Inc

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic agents and products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used … Show more

P/E ratio
2500.00x
vs. 62.11x forward

Price is 2500.00x times more than EPS €0.008 which eaquals €20.0

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Ms. Mary Anne Heino
Market capitalization
Small (1.33B)